Bye bye Sumitomo

[anonymous]

They have moved women’s health into MSPEC reps, more share of voice and smaller territories. Great decision by upper management

Both MSPEC and Women’s Health will form a new division.

 

[anonymous]

Both MSPEC and Women’s Health will form a new division.

Yeah it’ll be called the unemployment line.

 

[anonymous]

Across the organization beyond commercial, do you think there will be any cuts in early 2025, January-April? A lot of teams are getting aggressive and combative the last 2 months as if there is a strong chance there could be.

 

[anonymous]

Across the organization beyond commercial, do you think there will be any cuts in early 2025, January-April? A lot of teams are getting aggressive and combative the last 2 months as if there is a strong chance there could be.

history shows the japs do smaller cuts in the March window and the larger cuts in the Sept/Oct window. its gone down exactly this way in the past few years. Expect 2025 to be no different.

 

[anonymous]

history shows the japs do smaller cuts in the March window and the larger cuts in the Sept/Oct window. its gone down exactly this way in the past few years. Expect 2025 to be no different.

Yep I am sure there are more changes to come. No one is safe here unless you’re in oncology and even those reps are unhappy.

 

[anonymous]

Yep I am sure there are more changes to come. No one is safe here unless you’re in oncology and even those reps are unhappy.

Why are they unhappy? They have it made in the shade. High salaries and they do whatever they want.

 

[anonymous]

Why are they unhappy? They have it made in the shade. High salaries and they do whatever they want.

The japs vision is to make the US a small oncology only company. Look they are annually cutting the rest of the sales forces as part of their 5 year plan to get there. They need 2 more years.

 

[anonymous]

How do you know all of this? Are you one of the japs?

 

[anonymous]

How do you know all of this? Are you one of the japs?

this is very obvious. no need to be Japanese to know this. It’s been mentioned on here that all one has to do is go back and look what the japs have done over the past few years. Now if you’re a troll, that explains why you would not know this.

 

[Score Keeper]

Manager said JR finally left, was exposed after MD got canned. Now we wait to see which DEI candidate gets the old wink and nod as the new ASD to replace her.

 

[anonymous]

You always use the word “troll” on here. You must have a lot of time on your hands as you seem to never be working

 

[anonymous]

When you look back, 2021-to early 2023 there was no serious effort made by leadership or finance to cut back on spending, conserve cash or aggressively negotiate contracts before Latuda LOE. Nothing. Even if Ulotaront had been successful and somewhat on time, the commercial ramp up on a schiz drug was going to be slow. And it was clear by then the Urovant and myovant drug revenue were slow and way off the mark.

 

[anonymous]

You always use the word “troll” on here. You must have a lot of time on your hands as you seem to never be working

You must still be living 20 years ago with a dang flip phone and surfing the net at home with your modem internet Connection. You go cowboy!